Form D · Biotechnology
Neurodyn Life Sciences Inc.
Vancouver, A1 · CIK 0001568852
Offering snapshot reported Nov 2, 2015 · SEC filing
- Reported sold
- $23.1K Offering amount: $23.1K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 19, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 2, 2015 | Initial | $23,079 | No comparison | 1 | SEC filing |
| Oct 16, 2015 | Initial | $650,000 | No comparison | 2 | SEC filing |
| Mar 11, 2015 | Amendment | $1,408,880 | $747,932vs Sep 25, 2014 | 7 | SEC filing |
| Dec 8, 2014 | Amendment | $896,380 | $235,432vs Sep 25, 2014 | 6 | SEC filing |
| Sep 25, 2014 | Initial | $349,185 | No comparison | 1 | SEC filing |
| Sep 25, 2014 | Initial | $660,948 | No comparison | 5 | SEC filing |
| Jun 12, 2013 | Initial | $100,280 | No comparison | 1 | SEC filing |
| Apr 9, 2013 | Initial | $24,572 | No comparison | 1 | SEC filing |
| Feb 6, 2013 | Initial | $1,001,402 | No comparison | 1 | SEC filing |
| Feb 6, 2013 | Initial | $125,874 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-250509
Cdn$1.2999=US$1.00
Source: Form D, filed Nov 2, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kenneth A. Cawkell | Director, Executive |
| Robert L. Cervelli | Director |
| Richard Devries | Director |
| Scott Homenick | Executive |
| Denis G. Kay | Director, Executive |
| Alfred Maelicke | Director |
| James Mertz | Director |
| Madolyn Mertz | Director |
| Len Mertz | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
439 Helmcken Street
Vancouver, A1, V6B 2E6
Vancouver, A1, V6B 2E6